Immunogenicity of anti-TNF-α biotherapies.II. Clinical relevance of methods used for anti-drug antibody detection

Immunogenicity of biopharmaceuticals is complex and influenced by both structural and pharmacological factors, and by patient-related conditions such as disease being treated, previous and concomitant therapies and individual immune responsiveness. Essential for tailored therapeutic strategies based...

Celý popis

Podrobná bibliografie

Hlavní autor:	Klaus eBendtzen
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2015-04-01
Edice:	Frontiers in Immunology
Témata:	Immunogenicity Enzyme-linked immunosorbent assay (ELISA) Anti-drug antibodies Anti-TNF biopharmaceuticals homogeneous mobility-shift assay (HMSA) cell-based reporter-gene assay (RGA)
On-line přístup:	http://journal.frontiersin.org/Journal/10.3389/fimmu.2015.00109/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!